Provider review
MaxLife review
Names its compounding pharmacy, and prices the two molecules twenty dollars apart.
Provenance is the part of a compounded purchase a reader can least easily check, and it is stated here rather than implied.
Reviewed by Lena OrtizMetabolic Health Editor
Price updated August 2026
How we’re funded. Some links here are affiliate links: start care through one and we may earn a commission, at no extra cost to you. Affiliate partners are listed first on our rankings — what we write about a provider is the same either way, and unflattering findings about one that pays us stay in. Full disclosure.
Price as published
MaxLife
$100/mo sema · $120/mo tirz
FDA warning letter · MaxLife · February 2026 · addressed to MaxLife Technologies Inc. dba Maxlife. Details in our review.
- Vs median
- $69/mo below the $169 median
- Market
- $59–$1300/mo across 242 of 373
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Compounded by Hallandale Pharmacy
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
In one paragraph
The verdict
Two figures, one per molecule, both low, both visible without an intake, and a compounding pharmacy named on the page. That combination is rarer than it sounds. The naming matters more than a reader might assume: provenance is part of what you are buying with a compounded drug, and the difference between a seller that names its pharmacy and one that says only "licensed partners" is the difference between a claim you can check and one you cannot. The company is also unusually candid about what it is, describing itself as a platform that arranges access to care rather than as the manufacturer or the pharmacy. The narrow gap between the two molecules is the other thing to notice. Twenty dollars between them is much tighter than this category usually manages, and it means the choice can be made on clinical grounds rather than on price, which is how it ought to be made. What is missing is the same thing missing almost everywhere: no milligram sits behind either number. For a reader intending to hold a deliberately small dose that is the whole question, because a figure with no quantity attached cannot be tested against the amount of drug actually dispensed, and there is nothing to say whether the price moves as the dose climbs. The asterisk on the semaglutide page points at a condition the page itself does not spell out.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
Who it suits, and who it does not
A good fit if
- You want to know which pharmacy compounds what you inject before you order it
- You are choosing between the two molecules and would rather not have price decide it
- You want a low figure per molecule that is readable without completing an intake
Look elsewhere if
- You need to match a price to a milligram. Neither figure carries a dose
- You want to know what happens to the bill as you titrate upward. Nothing says
- You want the condition behind the asterisk resolved before you commit
What it actually costs
Price as published
Compounded semaglutide $100/mo and compounded tirzepatide $120/mo, each priced as its own program and both readable before intake · ★ the gap between the two is $20, which is far narrower than the usual spread and leaves the dual agonist unusually close to the single one · ★★ the compounding pharmacy is NAMED — Hallandale Pharmacy is identified among the licensed partners, which most of this category declines to do · the semaglutide formula is stated to include B vitamins · the semaglutide page carries an asterisk on its figure and no dose is published behind either price, so what quantity of drug either buys is unstated · the company describes itself as a wellness platform that facilitates access to care rather than a manufacturer or pharmacy · fulfillment is stated at two to three business days from the pharmacy
- Vs median
- $69/mo below the $169 median across the 242 of 373 programs we track that publish a plain monthly rate
- Market
- $59–$1300/mo is the full published spread in our ranking
- Structure
- Standard plan, self-directed low dose
No low-dose product of its own. Starting low means asking for a smaller amount inside a standard plan, at the standard plan's price.
152 of the 373 programs we track price a small dose this way. ★★ The compounding pharmacy is NAMED rather than described as a licensed partner, which is uncommon here and is the part of a compounded purchase a reader can least easily check for themselves. Both molecules carry their own figure and the gap between them is narrow enough that the choice can be made clinically rather than on cost. No low-dose product is offered, no dose sits behind either price, and nothing states whether either figure holds as the dose climbs — so a reader intending to hold a small amount cannot tell what share of the charge buys drug they will not use.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
What is included
- Consult
- Included in the price
- Dietitian
- Not included
- Labs
- Not required
- Pricing
- Varies by dose, plan or tier
- Price last updated
- August 2026
What it does well
- The compounding pharmacy is named rather than described only as a licensed partner.
- Both molecules are priced separately and both figures are low for compounded weekly shots.
- The gap between the two is small enough that the choice can be made clinically.
Pharmacy, labs and oversight
MaxLife dispenses through a Hallandale Pharmacy facility. No bloodwork is required before you start. A clinician review is included in the price.
Transparency check
2 of 4 published openly
What MaxLife publishes about itself, read from its own pages when we verified them — not estimated, and not a score.
- Pharmacy named and regulatedNo pharmacy is identified anywhere we could find on its own pages.
- Published
- A price you can read before intakeA monthly rate is published on its own pages — the figure in the price row above, read there and verified against it.
- Published
- What a higher dose costsPriced by dose, plan or tier, and the higher rungs are not published — the advertised figure does not tell you what a larger dose costs.
- Not published
- FDA warning letter on fileOne is on file. The disclosure and the FDA's own database are directly below.
- On file
FDA warning letter
The U.S. Food and Drug Administration issued a warning letter to MaxLife in February 2026. It is addressed to MaxLife Technologies Inc. dba Maxlife — search that name, not ours, to find it. We are not summarizing what it says — read it at the source. This does not change how MaxLife is listed here or whether we are paid for a click to it, and we would rather you knew both of those things at once.
How the program works
Two figures, one per molecule, both low, both visible without an intake, and a compounding pharmacy named on the page. That combination is rarer than it sounds. The naming matters more than a reader might assume: provenance is part of what you are buying with a compounded drug, and the difference between a seller that names its pharmacy and one that says "licensed U.S. partners" is the difference between a claim you can check and one you cannot. MaxLife is also unusually candid about what it is, describing itself as a platform that arranges access to care rather than as the manufacturer or the pharmacy. The narrow gap between the two molecules is the other thing to notice. Twenty dollars between semaglutide and tirzepatide is much tighter than this category usually manages, and it means the choice between them can be made on clinical grounds rather than on price, which is how it ought to be made. What is missing is the same thing missing almost everywhere: no milligram sits behind either number. For a reader intending to hold a deliberately small dose that is the whole question, because a figure with no quantity attached cannot be tested against the amount of drug actually dispensed, and there is no indication whether the price moves as the dose climbs. The asterisk on the semaglutide page points at a condition the rendered page does not spell out.
The honest cons
No dose sits behind either figure, so neither can be matched to an amount of drug.
- Nothing says whether either price holds as the dose is increased.
- The semaglutide figure carries an asterisk whose condition is not spelled out.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
How it compares
MaxLife is one of 373 low-dose GLP-1 programs we track, and 242 of them publish a monthly rate you can read before signing up. The ranking lists every published price on one screen, ordered with the companies that pay us first — a mechanism we state there, on the page it applies to.
Where this sits
#231 of 373
Ordered with the companies that pay us first, and MaxLife is not one of them. A disclosed partition, not a score.
Compare all 373 providers →Read this before you buy
Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.
- What microdosing GLP-1 costs
- Is compounded GLP-1 safe?
- Microdosing semaglutide
- The true annual cost of a plan
- What a flat price costs at a low dose
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
The closest alternative
RxSpan MD
From $194/mo
- Vs median
- $25/mo above the $169 median
- Market
- $59–$1300/mo across 242 of 373
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
Read the RxSpan MD review →Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.